Study to Investigate the Effect of GSK1014802 on Ambulatory Blood Pressure

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
In this study the investigators will determine whether there is any effect of GSK1014802 on ambulatory blood pressure. This will be a randomized, double-blind, placebo-controlled, repeat dose, 2 period cross-over study conducted in healthy male and female subjects. Approximately 60 subjects will be randomised to receive GSK1014802 400 mg bid and placebo for 36 days with at least 1 week between treatment sessions. A follow-up will occur 7-14 days after the last dose.
Epistemonikos ID: 70f7d82cba8830309df1eb7eaaad9352804ae5cc
First added on: May 05, 2024